发明名称 Methods and compositions using Klotho-FGF fusion polypeptides
摘要 The present invention is directed to fusion polypeptides comprising a Klotho protein or an active fragment thereof and FGF23 or an active fragment thereof.
申请公布号 US9458209(B2) 申请公布日期 2016.10.04
申请号 US201313904574 申请日期 2013.05.29
申请人 NOVARTIS AG 发明人 Glass David;Hu Shou-Ih
分类号 A61K38/18;A61K39/395;C07K14/50;C07K16/00;C12N1/21;C12N5/10;C07K14/435;C12N9/24;A61K38/00 主分类号 A61K38/18
代理机构 代理人 Le Hong-Van M.
主权项 1. A fusion polypeptide comprising, in order from N-terminus to C-terminus, a polypeptide comprising the sequence of amino acids 34 to 982 of SEQ ID NO: 19; one or more linkers; and a polypeptide comprising the sequence of amino acids 1000 to 1228 of SEQ ID NO: 19, wherein the fusion polypeptide is capable of activating Egr-1.
地址 Basel CH